Phathom Pharmaceuticals, Inc. PHAT Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s common stock?
- Phathom Pharmaceuticals, Inc. (PHAT) reported common stock of $7K in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s common stock changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s common stock increased by 16.7% year-over-year, from $6K to $7K.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s common stock?
- Over 5 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s common stock has grown at a 14.9% compound annual growth rate (CAGR), from $3K to $6K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).